SOURCE: Medisys Corproation

May 09, 2006 11:35 ET

MediSys Corporation Engages Experienced Sales Pro in Broward County Florida

PALM BEACH GARDENS, FL -- (MARKET WIRE) -- May 9, 2006 --MediSys Corporation (OTC: MDYS) today announced it has entered into an agreement with Mrs. Kelly A. Bradley, an experienced Pharmaceutical Representative to manage Broward County, Florida. Formerly with AstraZeneca, Innovex/Colombia Labs, and Tyco Health Care with six years of Health Care and Pharmaceutical sales to the Internal Medicine, Family Medicine, Urology and Cardiology markets, Ms. Bradley said, "I am excited to be able to offer the The MaxLife Center for Men™ to physicians in Fort Lauderdale and Broward County. The System is a natural fit for the doctors I have been calling on, as they are also the target market for MediSys. I feel good about leveraging my relationships and converting them to MediSys clients because not only can I help the doctors enhance their practice revenues and save their practices, but they will also be able to save more lives."

She continued, "When I first saw the The MaxLife Center for Men™. I knew it was a perfect fit, and I wanted the position because the management team at MediSys Corporation has done a fantastic job in developing the system and in creating the right offer at the right time. I know I can sell it. I am truly excited about offering this to the physicians I have been calling on all these years."

MediSys Corporation Chief Executive Officer Joshua Konigsberg commented, "We are thrilled about this and having Ms. Bradley's experience in becoming our Representative in the Broward County market. Kelly's former experience with the AstraZeneca and Innovex/Colombia Labs coupled with her existing relationships will allow for rapid penetration into the Broward market. Kelly's decision to join MediSys simply edifies what we have been saying about the market conditions of our target customer."

About MediSys

MediSys Corporation provides medical diagnostic solutions to physicians in the internal medicine, family practice and general practice markets. The Company's innovative clinical programs are easily integrated into the physicians practice, are cost-effective and enhance patient care. These programs or "systems" enable doctors to provide superior medical diagnostics & treatment while significantly improving their revenues and profits.

Disclaimer Regarding Forward-Looking Statements: This announcement may contain certain forward-looking statements that are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated. Forward-looking statements speak only as of the date the statement was made. The Company assumes no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. If the Company does update any forward-looking statement, no inference should be drawn that the Company will make additional updates with respect to that statement or any other forward-looking statements.

Contact Information

  • Contact :
    Brian Gibson
    800 Village Square Crossing
    Suite 201
    Palm Beach Gardens, FL 33410
    Tel: 561-622-5889
    Fax: 561-656-2099
    e-mail: Email Contact
    www.medisyscorp.com